Planning

Additive Solution for the washing and re-suspension of Red Blood Cell components suitable for transfusion

NHS BLOOD AND TRANSPLANT

This public procurement record has 4 releases in its history.

PlanningUpdate

20 May 2025 at 06:40

UK2 - Preliminary Market Engagement Notice
Planning

19 May 2025 at 07:49

UK2 - Preliminary Market Engagement Notice
Planning

19 May 2025 at 07:49

UK2 - Preliminary Market Engagement Notice
Planning

01 Apr 2025 at 13:48

UK2 - Preliminary Market Engagement Notice
Summary of the contracting process

NHS Blood and Transplant (NHSBT), a central government public authority based in Bristol, UK, is currently in the planning stage of a tender process involving the procurement of additive solutions for the washing and re-suspension of red blood cell components suitable for transfusion. The tender, titled "Additive Solution for the washing and re-suspension of Red Blood Cell components suitable for transfusion," invites expressions of interest by 30th June 2025. This procurement exercise falls under the medical solutions industry category and is valued at approximately £240,000, although the total gross value is £288,000. This initiative is aimed at sourcing sterile solutions such as SAG-M or PAGGSM, and ensuring compliance with UK transfusion guidelines. The engagement process will help NHSBT assess market capabilities and supplier readiness, with the future possibility of formal tenders or contracts post-2026.

This tender represents a notable opportunity for businesses specialising in pharmaceutical products, blood substitutes, and infusion supplies, specifically those manufacturing red cell additive solutions. Innovative suppliers capable of providing sterile, well-labelled solutions that are compatible with NHSBT's specialised washing processes can leverage this engagement to showcase their capabilities and secure long-term government contracts. The engagement particularly suits small and medium-sized enterprises (SMEs) looking to expand their footprint in the healthcare sector by collaborating with a central public authority. Participants can benefit by aligning their product offerings with NHSBT’s specific requirements and potentially positioning themselves for further procurement opportunities leading up to and beyond the commencement date of 1st November 2026.

Find more tenders on our Open Data Platform.
How relevant is this notice?

D3 Tenders Premium

Win More Public Sector Contracts

AI-powered tender discovery, pipeline management, and market intelligence — everything you need to grow your public sector business.

Start Free Trial Book a Demo
All Features Pricing

Notice Information

Notice Title

Additive Solution for the washing and re-suspension of Red Blood Cell components suitable for transfusion

Notice Description

NHS Blood and Transplant (NHSBT) invites expressions of interest from potential suppliers (of an existing product) or manufacturers capable of manufacturing any approved red cell storage solution, for example (but not limited to) SAG-M (Saline-Adenine-Glucose-Mannitol) or PAGGSM (Phosphate-Adenine-Glucose-Guanylate-Saline-Mannitol), for Additive Solution for the washing and re-suspension of Red Blood Cell components suitable for transfusion. Washed components must meet the requirements of Guidelines for the Blood Transfusion and Tissue Transplantation Services in the UK, section 7.3.3. which can be found here: https://www.transfusionguidelines.org/red-book/chapter-7/7-3/7-3-3 This engagement aims to assess market capability, capacity, and interest in supplying a sterile, labelled product. Requirement Interested parties must be able to supply or manufacture additive solution bags that meet the following criteria: - Solution Type: SAG-M or PAGGSM or other approved red cell storage solution - Sterility: Bags must be sterile and suitable for clinical use - Design: Each bag must include a pigtail for sterile docking - Labeling: Bags must be clearly and accurately labelled in accordance with applicable regulatory standards - Compatibility: The solution must be suitable for use in NHSBTs red blood cell washing processes Supplier Engagement Objectives Through this engagement, NHSBT seeks to: - Understand the current market landscape and supplier capabilities - Identify potential suppliers for future procurement opportunities - Gather feedback on product availability, lead times, and regulatory compliance Next Steps Suppliers interested in participating in this market engagement are invited to express their interest by contacting samantha.rix@nhsbt.nhs.uk . Further information, including a questionnaire or Request for Information (RFI), may be issued following initial expressions of interest. No business whatsoever is guaranteed under any resulting framework or contract, and there is no guarantee that any framework or contract will be put in place in relation to this notice. Each Potential Supplier is responsible for all costs and expenses incurred in relation to this Market Engagement exercise, each Potential Supplier accepts by its participation in this process, including without limitation the submission of any documents or attending meetings, that it will not be entitled to claim from NHSBT any costs, expenses or liabilities that it may incur irrespective of whether or not its tender is successful or if a tender or resulting framework or contract is withdrawn for any reason.

Planning Information

NHS Blood and Transplant (NHSBT) invites expressions of interest from potential suppliers (of an existing product) or manufacturers capable of manufacturing any approved red cell storage solution, for example (but not limited to) SAG-M (Saline-Adenine-Glucose-Mannitol) or PAGGSM (Phosphate-Adenine-Glucose-Guanylate-Saline-Mannitol), for Additive Solution for the washing and re-suspension of Red Blood Cell components suitable for transfusion. Washed components must meet the requirements of Guidelines for the Blood Transfusion and Tissue Transplantation Services in the UK, section 7.3.3. which can be found here: https://www.transfusionguidelines.org/red-book/chapter-7/7-3/7-3-3 This engagement aims to assess market capability, capacity, and interest in supplying a sterile, labelled product. Requirement Interested parties must be able to supply or manufacture additive solution bags that meet the following criteria: - Solution Type: SAG-M or PAGGSM or other approved red cell storage solution - Sterility: Bags must be sterile and suitable for clinical use - Design: Each bag must include a pigtail for sterile docking - Labeling: Bags must be clearly and accurately labelled in accordance with applicable regulatory standards - Compatibility: The solution must be suitable for use in NHSBTs red blood cell washing processes Supplier Engagement Objectives Through this engagement, NHSBT seeks to: - Understand the current market landscape and supplier capabilities - Identify potential suppliers for future procurement opportunities - Gather feedback on product availability, lead times, and regulatory compliance Next Steps Suppliers interested in participating in this market engagement are invited to express their interest by contacting samantha.rix@nhsbt.nhs.uk . Further information, including a questionnaire or Request for Information (RFI), may be issued following initial expressions of interest. No business whatsoever is guaranteed under any resulting framework or contract, and there is no guarantee that any framework or contract will be put in place in relation to this notice. Each Potential Supplier is responsible for all costs and expenses incurred in relation to this Market Engagement exercise, each Potential Supplier accepts by its participation in this process, including without limitation the submission of any documents or attending meetings, that it will not be entitled to claim from NHSBT any costs, expenses or liabilities that it may incur irrespective of whether or not its tender is successful or if a tender or resulting framework or contract is withdrawn for any reason.

Notice Details

Publication & Lifecycle

Open Contracting ID
ocds-h6vhtk-04fb6d
Publication Source
Find A Tender Service
Latest Notice
https://www.find-tender.service.gov.uk/Notice/022921-2025
Current Stage
Planning
All Stages
Planning

Procurement Classification

Notice Type
UK2 - Preliminary Market Engagement Notice
Procurement Type
Standard
Procurement Category
Goods
Procurement Method
Not Specified
Procurement Method Details
Not specified
Tender Suitability
SME
Awardee Scale
Not specified

Common Procurement Vocabulary (CPV)

CPV Divisions

24 - Chemical products

33 - Medical equipments, pharmaceuticals and personal care products

CPV Codes

24000000 - Chemical products

24950000 - Specialised chemical products

33141613 - Blood bags

33194220 - Blood-transfusion supplies

33600000 - Pharmaceutical products

33621400 - Blood substitutes and perfusion solutions

33692000 - Medical solutions

Notice Value(s)

Tender Value
£240,000 £100K-£500K
Lots Value
Not specified
Awards Value
Not specified
Contracts Value
Not specified

Notice Dates

Publication Date
20 May 20259 months ago
Submission Deadline
Not specified
Future Notice Date
1 Apr 20262 months to go
Award Date
Not specified
Contract Period
1 Nov 2026 - 31 Oct 2028 2-3 years
Recurrence
Not specified

Notice Status

Tender Status
Planning
Lots Status
Planning
Awards Status
Not Specified
Contracts Status
Not Specified

Buyer & Supplier

Contracting Authority (Buyer)

Main Buyer
NHS BLOOD AND TRANSPLANT
Contact Name
Samantha Rix
Contact Email
samantha.rix@nhsbt.nhs.uk
Contact Phone
Not specified

Buyer Location

Locality
BRISTOL
Postcode
BS34 7QH
Post Town
Bristol
Country
England
Major Region (ITL 1)
TLK South West (England)
Basic Region (ITL 2)
TLK5 West of England
Small Region (ITL 3)
TLK52 Bath & North East Somerset and South Gloucestershire
Delivery Location
Not specified
Local Authority
South Gloucestershire
Electoral Ward
Filton
Westminster Constituency
Filton and Bradley Stoke

Further Information

Notice Documents

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

Download

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts. 

{
    "tag": [
        "compiled"
    ],
    "id": "ocds-h6vhtk-04fb6d-2025-05-20T07:40:19+01:00",
    "date": "2025-05-20T07:40:19+01:00",
    "ocid": "ocds-h6vhtk-04fb6d",
    "initiationType": "tender",
    "parties": [
        {
            "id": "GB-PPON-PDBY-6395-VWBP",
            "name": "NHS Blood and Transplant",
            "identifier": {
                "scheme": "GB-PPON",
                "id": "PDBY-6395-VWBP"
            },
            "address": {
                "streetAddress": "500 North Bristol Park",
                "locality": "Bristol",
                "postalCode": "BS34 7QH",
                "country": "GB",
                "countryName": "United Kingdom",
                "region": "UKK12"
            },
            "contactPoint": {
                "name": "Samantha Rix",
                "email": "samantha.rix@nhsbt.nhs.uk"
            },
            "roles": [
                "buyer"
            ],
            "details": {
                "url": "https://www.nhsbt.nhs.uk/",
                "classifications": [
                    {
                        "scheme": "UK_CA_TYPE",
                        "id": "publicAuthorityCentralGovernment",
                        "description": "Public authority - central government"
                    }
                ]
            }
        }
    ],
    "buyer": {
        "id": "GB-PPON-PDBY-6395-VWBP",
        "name": "NHS Blood and Transplant"
    },
    "planning": {
        "milestones": [
            {
                "id": "engagement",
                "type": "engagement",
                "description": "NHS Blood and Transplant (NHSBT) invites expressions of interest from potential suppliers (of an existing product) or manufacturers capable of manufacturing any approved red cell storage solution, for example (but not limited to) SAG-M (Saline-Adenine-Glucose-Mannitol) or PAGGSM (Phosphate-Adenine-Glucose-Guanylate-Saline-Mannitol), for Additive Solution for the washing and re-suspension of Red Blood Cell components suitable for transfusion. Washed components must meet the requirements of Guidelines for the Blood Transfusion and Tissue Transplantation Services in the UK, section 7.3.3. which can be found here: https://www.transfusionguidelines.org/red-book/chapter-7/7-3/7-3-3 This engagement aims to assess market capability, capacity, and interest in supplying a sterile, labelled product. Requirement Interested parties must be able to supply or manufacture additive solution bags that meet the following criteria: - Solution Type: SAG-M or PAGGSM or other approved red cell storage solution - Sterility: Bags must be sterile and suitable for clinical use - Design: Each bag must include a pigtail for sterile docking - Labeling: Bags must be clearly and accurately labelled in accordance with applicable regulatory standards - Compatibility: The solution must be suitable for use in NHSBTs red blood cell washing processes Supplier Engagement Objectives Through this engagement, NHSBT seeks to: - Understand the current market landscape and supplier capabilities - Identify potential suppliers for future procurement opportunities - Gather feedback on product availability, lead times, and regulatory compliance Next Steps Suppliers interested in participating in this market engagement are invited to express their interest by contacting samantha.rix@nhsbt.nhs.uk . Further information, including a questionnaire or Request for Information (RFI), may be issued following initial expressions of interest. No business whatsoever is guaranteed under any resulting framework or contract, and there is no guarantee that any framework or contract will be put in place in relation to this notice. Each Potential Supplier is responsible for all costs and expenses incurred in relation to this Market Engagement exercise, each Potential Supplier accepts by its participation in this process, including without limitation the submission of any documents or attending meetings, that it will not be entitled to claim from NHSBT any costs, expenses or liabilities that it may incur irrespective of whether or not its tender is successful or if a tender or resulting framework or contract is withdrawn for any reason.",
                "dueDate": "2025-06-30T23:59:59+01:00",
                "status": "scheduled"
            }
        ],
        "documents": [
            {
                "id": "012299-2025",
                "documentType": "marketEngagementNotice",
                "noticeType": "UK2",
                "description": "Preliminary market engagement notice on Find a Tender",
                "url": "https://www.find-tender.service.gov.uk/Notice/012299-2025",
                "datePublished": "2025-04-01T14:48:26+01:00",
                "format": "text/html"
            },
            {
                "id": "022434-2025",
                "documentType": "marketEngagementNotice",
                "noticeType": "UK2",
                "description": "Preliminary market engagement notice on Find a Tender",
                "url": "https://www.find-tender.service.gov.uk/Notice/022434-2025",
                "datePublished": "2025-05-19T08:49:08+01:00",
                "format": "text/html"
            },
            {
                "id": "022435-2025",
                "documentType": "marketEngagementNotice",
                "noticeType": "UK2",
                "description": "Preliminary market engagement notice on Find a Tender",
                "url": "https://www.find-tender.service.gov.uk/Notice/022435-2025",
                "datePublished": "2025-05-19T08:49:31+01:00",
                "format": "text/html"
            },
            {
                "id": "022921-2025",
                "documentType": "marketEngagementNotice",
                "noticeType": "UK2",
                "description": "Preliminary market engagement notice on Find a Tender",
                "url": "https://www.find-tender.service.gov.uk/Notice/022921-2025",
                "datePublished": "2025-05-20T07:40:19+01:00",
                "format": "text/html"
            }
        ]
    },
    "tender": {
        "id": "C351077",
        "legalBasis": {
            "id": "2023/54",
            "scheme": "UKPGA",
            "uri": "https://www.legislation.gov.uk/ukpga/2023/54/contents"
        },
        "title": "Additive Solution for the washing and re-suspension of Red Blood Cell components suitable for transfusion",
        "description": "NHS Blood and Transplant (NHSBT) invites expressions of interest from potential suppliers (of an existing product) or manufacturers capable of manufacturing any approved red cell storage solution, for example (but not limited to) SAG-M (Saline-Adenine-Glucose-Mannitol) or PAGGSM (Phosphate-Adenine-Glucose-Guanylate-Saline-Mannitol), for Additive Solution for the washing and re-suspension of Red Blood Cell components suitable for transfusion. Washed components must meet the requirements of Guidelines for the Blood Transfusion and Tissue Transplantation Services in the UK, section 7.3.3. which can be found here: https://www.transfusionguidelines.org/red-book/chapter-7/7-3/7-3-3 This engagement aims to assess market capability, capacity, and interest in supplying a sterile, labelled product. Requirement Interested parties must be able to supply or manufacture additive solution bags that meet the following criteria: - Solution Type: SAG-M or PAGGSM or other approved red cell storage solution - Sterility: Bags must be sterile and suitable for clinical use - Design: Each bag must include a pigtail for sterile docking - Labeling: Bags must be clearly and accurately labelled in accordance with applicable regulatory standards - Compatibility: The solution must be suitable for use in NHSBTs red blood cell washing processes Supplier Engagement Objectives Through this engagement, NHSBT seeks to: - Understand the current market landscape and supplier capabilities - Identify potential suppliers for future procurement opportunities - Gather feedback on product availability, lead times, and regulatory compliance Next Steps Suppliers interested in participating in this market engagement are invited to express their interest by contacting samantha.rix@nhsbt.nhs.uk . Further information, including a questionnaire or Request for Information (RFI), may be issued following initial expressions of interest. No business whatsoever is guaranteed under any resulting framework or contract, and there is no guarantee that any framework or contract will be put in place in relation to this notice. Each Potential Supplier is responsible for all costs and expenses incurred in relation to this Market Engagement exercise, each Potential Supplier accepts by its participation in this process, including without limitation the submission of any documents or attending meetings, that it will not be entitled to claim from NHSBT any costs, expenses or liabilities that it may incur irrespective of whether or not its tender is successful or if a tender or resulting framework or contract is withdrawn for any reason.",
        "items": [
            {
                "id": "1",
                "additionalClassifications": [
                    {
                        "scheme": "CPV",
                        "id": "33692000",
                        "description": "Medical solutions"
                    },
                    {
                        "scheme": "CPV",
                        "id": "33621400",
                        "description": "Blood substitutes and perfusion solutions"
                    },
                    {
                        "scheme": "CPV",
                        "id": "33194220",
                        "description": "Blood-transfusion supplies"
                    },
                    {
                        "scheme": "CPV",
                        "id": "33141613",
                        "description": "Blood bags"
                    },
                    {
                        "scheme": "CPV",
                        "id": "33600000",
                        "description": "Pharmaceutical products"
                    },
                    {
                        "scheme": "CPV",
                        "id": "24000000",
                        "description": "Chemical products"
                    },
                    {
                        "scheme": "CPV",
                        "id": "24950000",
                        "description": "Specialised chemical products"
                    }
                ],
                "deliveryAddresses": [
                    {
                        "region": "UK",
                        "country": "GB",
                        "countryName": "United Kingdom"
                    }
                ],
                "relatedLot": "1"
            }
        ],
        "value": {
            "amountGross": 288000,
            "amount": 240000,
            "currency": "GBP"
        },
        "mainProcurementCategory": "goods",
        "aboveThreshold": true,
        "lots": [
            {
                "id": "1",
                "suitability": {
                    "sme": true
                },
                "contractPeriod": {
                    "startDate": "2026-11-01T00:00:00Z",
                    "endDate": "2028-10-31T23:59:59Z",
                    "maxExtentDate": "2030-10-31T23:59:59Z"
                },
                "hasRenewal": true,
                "status": "planning"
            }
        ],
        "communication": {
            "futureNoticeDate": "2026-04-01T23:59:59+01:00"
        },
        "status": "planning",
        "amendments": [
            {
                "id": "022921-2025",
                "description": "Amending the Notice to include additional guidelines"
            }
        ]
    },
    "language": "en"
}